Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;182(1):138-146.
doi: 10.1111/bjd.18024. Epub 2019 May 13.

Inherited MC1R variants in patients with melanoma are associated with better survival in women

F E Lira  1 , S Podlipnik  1   2 , M Potrony  1   2   3 , G Tell-Martí  1   2   3 , N Calbet-Llopart  1   2 , A Barreiro  1   2 , C Carrera  1   2   3 , J Malvehy  1   2   3 , S Puig  1   2   3
Affiliations

Inherited MC1R variants in patients with melanoma are associated with better survival in women

F E Lira et al. Br J Dermatol. 2020 Jan.

Abstract

Background: Women have a better melanoma prognosis, and fairer skin/hair colour. The presence of inherited MC1R variants has been associated with a better melanoma prognosis, but its interaction with sex is unknown.

Objectives: To evaluate the relationship between germline MC1R status and survival, and determine any association with sex.

Methods: This was a cohort study including 1341 patients with melanoma from the Melanoma Unit of the Hospital Clinic of Barcelona, between January 1996 and April 2018. We examined known sex-related prognosis factors as they relate to features of melanoma and evaluated the sex-specific role of MC1R in overall and melanoma-specific survival. Hazard ratios (HRs) were calculated using univariate and multivariate Cox logistic regression.

Results: Men showed lower overall survival than women (P < 0·001) and the presence of inherited MC1R variants was not associated with better survival in our cohort. However, in women the presence of MC1R variants was associated with better overall survival in the multivariate analysis [HR 0·57, 95% confidence interval (CI) 0·38-0·85; P = 0·006] but not in men [HR 1·26, 95% CI 0·89-1·79; P = 0·185 (P-value for interaction 0·004)]. Analysis performed for melanoma-specific survival showed the same level of significance.

Conclusions: Inherited MC1R variants are associated with improved overall survival in women with melanoma but not in men. Intrinsic sex-dependent features can modify the role of specific genes in melanoma prognosis. We believe that survival studies of patients with melanoma should include analysis by sex and MC1R genotype. What's already known about this topic? Inherited MC1R variants have been associated with a better melanoma prognosis, but their interaction with sex is unknown. What does this study add? MC1R variants are related to better overall survival and melanoma-specific survival in women but not in men. What is the translational message? These differences between the sexes could imply future changes in melanoma follow-up and treatment strategies. This provides a basis for understanding the interaction between sex-related genes and germline variants in cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the study cohort.
Figure 2
Figure 2
Overall survival by sex.
Figure 3
Figure 3
Overall survival by MC1R status depending on sex.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9–29. - PubMed
    1. Balch CM, Gershenwald JE, Soong SJ et al Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199–206. - PMC - PubMed
    1. Joosse A, De Vries E, Eckel R et al Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 2011; 131:719–26. - PubMed
    1. Joosse A, Collette S, Suciu S et al Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials. J Clin Oncol 2012; 30:2240–7. - PubMed
    1. Joosse A, Collette S, Suciu S et al Sex is an independent prognostic indicator for survival and relapse/progression‐free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials. J Clin Oncol 2013; 31:2337–46. - PubMed

Publication types

Substances